Related Experiment Video
Updated: May 5, 2026
08:42
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
27.7K
Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of
Patrick G O'Malley1, Michael J Arnold1, Cathy Kelley2
1Uniformed Services University of the Health Sciences, Bethesda, Maryland (P.G.O., M.J.A., B.E.N.).
Annals of Internal Medicine
|September 21, 2020
Summary
The updated VA/DoD clinical practice guideline for dyslipidemia management focuses on statin dosing, not cholesterol targets, to reduce cardiovascular disease risk in adults. It provides evidence-based recommendations for prevention and treatment.
Area of Science:
- Cardiovascular Medicine
- Clinical Practice Guidelines
- Public Health
Background:
- The U.S. Department of Veterans Affairs (VA) and Department of Defense (DoD) jointly updated their clinical practice guideline for dyslipidemia in June 2020.
- This guideline aims to reduce cardiovascular disease (CVD) risk in adult populations.
- The update reflects current evidence and best practices in managing lipid disorders.
Purpose of the Study:
- To provide a synopsis of the major recommendations from the updated VA/DoD clinical practice guideline for dyslipidemia management.
- To highlight key areas including statin dosing, risk prediction, prevention strategies, and lifestyle modifications.
- To inform healthcare providers about the latest evidence-based approaches to CVD risk reduction.
Main Methods:
- The guideline development involved the VA/DoD Evidence-Based Practice Work Group (EBPWG) and clinical stakeholders.
- A systematic literature search was conducted for English-language publications from December 2013 to May 2019.
- Recommendations were developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system, resulting in 27 recommendations and an algorithm.
Main Results:
- The guideline emphasizes targeting statin dose intensity rather than specific low-density lipoprotein cholesterol (LDL-C) goals.
- Key areas covered include additional tests for CVD risk prediction.
- Recommendations address primary and secondary prevention, laboratory testing, physical activity, and nutrition for dyslipidemia management.
Conclusions:
- The updated guideline provides a comprehensive framework for managing dyslipidemia to effectively reduce cardiovascular disease risk.
- Healthcare providers are encouraged to implement these evidence-based recommendations in clinical practice.
- The focus on statin dosing and comprehensive risk assessment supports personalized patient care.
More Related Videos
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
01:18Lipids: Dietary Sources and Requirements
2.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.5K
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
859
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
859
01:26Coronary Artery Disease IV: Preventive Measures
891
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
01:27Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
01:26Atherosclerosis III: Management
747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747